DnB Asset Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-267,568
Closed -$1.08M – 736
2025
Q2
$1.08M Buy
267,568
+7,397
+3% +$24.1K ﹤0.01% 616
2025
Q1
$710K Buy
260,171
+32,900
+14% +$118K ﹤0.01% 639
2024
Q4
$966K Buy
+227,271
New +$865K ﹤0.01% 638
2022
Q1
– Sell
-76,768
Closed -$678K – 648
2021
Q4
$678K Buy
+76,768
New +$730K ﹤0.01% 640

Other funds holding SRTA

DnB Asset Management's SRTA Position: Q3 2025 in Review

DnB Asset Management sold out of Strata Critical Medical Inc (SRTA) in Q3 2025, closing a stake of 267,568 shares — an estimated $1.08M sold.

DnB Asset Management first reported a position in SRTA in Q4 2021 and held it in 4 quarters. The position peaked at $1.08M in Q2 2025. 137 funds tracked by Wall St. Rank hold SRTA as of Q3 2025.

  • DnB Asset Management reported no remaining Strata Critical Medical Inc position as of Q3 2025 after selling out during the quarter.
  • DnB Asset Management sold 267,568 Strata Critical Medical Inc shares in Q3 2025, an estimated $1.08M.
  • DnB Asset Management first reported a position in Strata Critical Medical Inc in Q4 2021 and held it in 4 quarters.
  • DnB Asset Management's Strata Critical Medical Inc position peaked at $1.08M in Q2 2025.
  • 137 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2025.

Based on DnB Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.